CanSino Biologics Inc.
Status: Publicly traded
Direct answer
CanSino Biologics Inc. is publicly traded on SHH under the ticker 688185.SS.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical...
Can you invest in CanSino Biologics Inc.?
Yes. CanSino Biologics Inc. trades publicly on SHH as 688185.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CanSino Biologics Inc.
Detailed equity research is provided by MarketSnap.